A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Dose Exploratory Trial Evaluating the Safety and Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven) in the Reduction of Bleeding in Subjects Undergoing Orthotopic Liver Transplantation
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Eptacog alfa (Primary)
- Indications Perioperative haemorrhage; Surgical blood loss
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 15 Apr 2015 New trial record